Targeting the fatty acid metabolizing enzyme Stearoyl-CoA desaturase-1 (SCD1) combined with anti-PD-1 also have a synergistic anti-tumor effect, by reducing Wnt/β-catenin signaling and promoting DCs recruitment (218). The gene discussed is PDCD1; the disease is neoplasm.